Effectively managing the biologics lifecycle

Amidst a surge of innovation, the biologics market faces unpredictability over volume needs in drug development. Companies are increasingly turning to CDMOs for flexible operation strategies, to adapt to changing manufacturing demands, and for long-term confidence and security.

Discover the crucial factors for success in the volatile biologics market, as they explore:

Navigating market complexity and implementing flexible operational models
The crucial role of selecting the right CDMO partner
Significance of the revision of ICH Q5A (R2) guidelines, the first update in 26 years
Key drivers for optimizing tech transfer
How partnering with Lonza can provide a reliable pathway to scaling success

Download the Ebook

Your company email address

Please select your industry: (max 1)

Opt In?

Berne Media may store and process my information. For details, see the Privacy Notice.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
I agree to Lonza using my details for marketing purposes subject to Privacy Policy.

Please complete all required fields to access the content!

Future-Ready Pharmacovigilance: Integrating AI With FDA's EDSTP Guidelines

Join IQVIA’s esteemed panel of experts for an in-depth discussion on how AI can meet and exceed these new expectations. This webinar delves into the intersection of regulatory frameworks and technological innovation, offering insights into the future of PV and how organizations can navigate this transformative field. Key takeaways include:

Accelerating Biologics Development With Strategies For Success

The biologics market is growing rapidly, unlocking exciting opportunities but also presenting significant challenges. Developers are undergoing pressure to accelerate the delivery of innovative therapies while addressing complex regulatory demands, navigating demanding clinical trial phases, efficiently scaling production, and maintaining quality. In this webinar, industry experts will share practical strategies and real-world examples to help you navigate these challenges. Key takeaways:

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering: